Malignant Liver Neoplasm — Research

Malignant Liver Neoplasm — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-28	40,293	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab])`	2026-09-28	pubmed
Last 5 years	2021-01-01 → 2026-12-31	17,939	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-28	pubmed
Preceding 5-year window	2020-09-28 → 2025-09-27	15,793	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2020/09/28:2025/09/27[dp])`	2026-09-28	pubmed
Last 12 months	2025-09-28 → 2026-09-28	3,252	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2025/09/28:2026/09/28[dp])`	2026-09-28	pubmed
y2016	2016-01-01 → 2016-12-31	1,650	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-28	pubmed
y2017	2017-01-01 → 2017-12-31	1,861	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-28	pubmed
y2018	2018-01-01 → 2018-12-31	1,999	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-28	pubmed
y2019	2019-01-01 → 2019-12-31	2,335	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-28	pubmed
y2020	2020-01-01 → 2020-12-31	2,725	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-28	pubmed
y2021	2021-01-01 → 2021-12-31	3,212	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-28	pubmed
y2022	2022-01-01 → 2022-12-31	3,379	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-28	pubmed
y2023	2023-01-01 → 2023-12-31	3,300	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-28	pubmed
y2024	2024-01-01 → 2024-12-31	3,666	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-28	pubmed
y2025	2025-01-01 → 2025-12-31	3,784	`("Malignant Liver Neoplasm"[tiab] OR "Liver Cancer"[tiab] OR "Cancer of Liver"[tiab] OR "Cancer of the Liver"[tiab] OR "Malignant neoplasm of liver, not specified as primary or secondary"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-28	pubmed

Data updated 2 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (72)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 51–72 of 72 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
· Br J Cancer · 2019 · PMID 30420614 · validated civic_curation pubmed
Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
· Br J Cancer · 2012 · PMID 22596232 · validated civic_curation pubmed
A phase II study of the efficacy and safety of the combination therapy of the MEK inhibitor refametinib (BAY 86-9766) plus sorafenib for Asian patients with unresectable hepatocellular carcinoma.
· Clin Cancer Res · 2014 · PMID 25294897 · validated civic_curation pubmed
Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma-2 case reports and a brief review.